2018, Number 6
<< Back Next >>
Ann Hepatol 2018; 17 (6)
ALBI and PALBI: Novel Scores for Outcome Prediction of Cirrhotic Outpatients Awaiting Liver Transplantation
Chedid MF, Picon RV, Chedid AD
Language: English
References: 7
Page: 906-907
PDF size: 111.32 Kb.
ABSTRACT
Cirrhosis has four different stages that encompass mild stable compensated cirrhosis, stable cirrhosis with prior decompensation,
acutely decompensated cirrhosis and acute-on-chronic liver failure. A worse ALBI score has been associated
to an increased mortality in a recent study involving patients with stable cirrhosis and prior decompensation.
REFERENCES
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
Chedid AD, Klein PW, Tiburi MF, Villwock MM, Bassani LE, Chedid MF. Spontaneous rupture of hepatocellular carcinoma with haemoperitoneum: a rare condition in Western countries. HPB (Oxford) 2001; 3: 227-30.
Jalan R, Pavesi M, Saliba F, Amorós A, Fernandez J, Holland- Fischer P, Sawhney R, et al. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalized cirrhotic patients without acute-on-chronic liver failure. J Hepatol 2015; 62: 831-40.
Picon RV, Bertol FS, Tovo CV, de Mattos ÂZ. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients. World J Gastroenterol 2017; 23: 5237-45.
Kim TY, Song DS, Kim HY, Sinn DH, Yoon EL, Kim CW, Jung YK, et al. Characteristics and Discrepancies in Acute-on- Chronic Liver Failure: Need for a Unified Definition. PLoS One 2016; 11: e0146745.
Oikonomou T, Goulis I, Doumtsis P, Tzoumari T, Akriviadis T, Cholongitas E. ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis. Ann Hepatol [In Press]. Doi: 10.5604/01.3001.0012.2234.
Pinato DJ, Sharma R, Allara E, Yen C, Arizumi T, Kubota K, Bettinger D, et al. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. J Hepatol 2017; 66: 338-46.